
cystinosis
Sign in to saveAlso known as Cystine storage disease, Cystinosis (disorder), Cystinosis (disorder) [Ambiguous], Cystinosis [dup] (disorder), Cystine disease, Protein defect of cystin transport, Cystinoses, Cystine diathesis
Cystinosis is a lysosomal storage disease characterized by the abnormal accumulation of free cystine, the oxidized dimer of the amino acid cysteine in lysosomes, eventually leading to intracellular crystal formation throughout the body, e.g. in kidneys.
Key facts
- Medical condition.name
- Cystinosis
- Medical condition.synonyms
- Cystine storage disease, Abderhalden–Lignac–Kaufmann disease, Abderhalden–Kaufmann–Lignac syndrome
- Medical condition.image
- Cystine-skeletal.png
- Medical condition.caption
- Chemical structure of cystine formed from L-cysteine (under biological conditions)
via Wikipedia infobox
Research
1,873 papers- Cystinosis.The New England journal of medicine · 2002
- Cystinosis.Journal of inherited metabolic disease · 1995
- Fertility in Cystinosis.Cells · 2021
- Cystinosis: a review.Orphanet journal of rare diseases · 2016
- Nephropathic cystinosis: an update on genetic conditioning.Pediatric nephrology (Berlin, Germany) · 2021
via PubMed
~17 min read
Encyclopedic overview
19 sectionsContents
- Classification
- Symptoms and signs
- Crystal morphology and identification
- Pathophysiology
- Diagnosis
- Complications
- Genetics
- Diagnosis
- Management
- Treatment
- Investigational treatments
- Gene therapy
- CRISPR gene editing
- Pharmacological therapies (Beyond Cysteamine)
- Prognosis
- History
- See also
- References
- External links
Cystinosis is a lysosomal storage disease characterized by the abnormal accumulation of free cystine, the oxidized dimer of the amino acid cysteine in lysosomes, eventually leading to intracellular crystal formation throughout the body, e.g. in kidneys.
It is genetically inheritable in the autosomal recessive fashion via CTNS (AR) gene. It characterized by systemic accumulation of the amino acid cystine within lysosomes, proximal tubulopathy and by progressive chronic kidney disease. If untreated, it leads to progressive cellular dysfunction and multiorgan involvement. The disease most commonly presents in infancy with renal Fanconi syndrome and, without treatment, progresses to end-stage kidney disease (ESKD) in childhood. Extra-renal manifestations affecting the eyes, thyroid, muscle, pancreas, and central nervous system may develop later in life. Early diagnosis and lifelong cystine-depleting therapy improve growth, delay progression to ESKD, and reduce many systemic complications. Nevertheless, despite treatment, the mean age at death for individuals born between 1985 and 1999 has been 29 years.
Excerpted from Wikipedia’s “cystinosis” article, available under the CC BY-SA 4.0 licence.